发明名称 |
ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF |
摘要 |
The present invention provides antibodies that bind to platelet derived growth factor receptor beta (PDGFR-beta) and methods of using the same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human PDGFR-beta with high affinity. The antibodies of the invention are useful for the treatment of diseases and disorders associated with PDGFR-beta signaling and/or PDGFR-beta cellular expression, such as ocular diseases, fibrotic diseases, vascular diseases and cancer. |
申请公布号 |
US2014193402(A1) |
申请公布日期 |
2014.07.10 |
申请号 |
US201414148753 |
申请日期 |
2014.01.07 |
申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
WIEGAND Stanley J.;LOBOV Ivan B. |
分类号 |
A61K39/395;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated antibody or antigen-binding fragment thereof that specifically binds monomeric human platelet derived growth factor receptor beta (PDGFR-beta) with a binding dissociation equilibrium constant (KD) of less than about 30 nM as measured in a surface plasmon resonance assay at 37° C. |
地址 |
TARRYTOWN NY US |